Literature DB >> 2564078

Oral contraceptives and breast cancer: is the CASH study really negative?

J Peto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2564078     DOI： 10.1016/s0140-6736(89)90088-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Risk for malignant tumors after oral contraceptive use: is it related to organ size while taking the pill?

Authors:  H Olsson
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

2.  Effects of short-term administration of human chorionic gonadotropin on immune functions in cryptorchid children.

Authors:  M Maghnie; A Valtorta; A Moretta; D Larizza; M A Girani; F Severi
Journal:  Eur J Pediatr       Date:  1991-02       Impact factor: 3.183

3.  Breast cancer risk factors in African-American women: the Howard University Tumor Registry experience.

Authors:  A E Laing; F M Demenais; R Williams; G Kissling; V W Chen; G E Bonney
Journal:  J Natl Med Assoc       Date:  1993-12       Impact factor: 1.798

Review 4.  Oral contraceptives and breast cancer.

Authors:  C E Chilvers; J M Deacon
Journal:  Br J Cancer       Date:  1990-01       Impact factor: 7.640

5.  Oral contraceptives and breast cancer in northern Italy. Final report from a case-control study.

Authors:  A Tavani; E Negri; S Franceschi; F Parazzini; C La Vecchia
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

6.  Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer.

Authors:  L Lipworth; C C Hsieh; L Wide; A Ekbom; S Z Yu; G P Yu; B Xu; S Hellerstein; K Carlstrom; D Trichopoulos; H O Adami
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

7.  Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism.

Authors:  W H Catherino; M H Jeng; V C Jordan
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.